Revolution Medicines (FRA:42Z) Marketable Securities : €1,636.44 Mil (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Revolution Medicines Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Revolution Medicines's Marketable Securities for the quarter that ended in Mar. 2025 was €1,636.44 Mil.

Revolution Medicines's annual Marketable Securities increased from Dec. 2022 (€456.45 Mil) to Dec. 2023 (€1,060.79 Mil) and increased from Dec. 2023 (€1,060.79 Mil) to Dec. 2024 (€1,667.65 Mil).

Revolution Medicines Marketable Securities Historical Data

The historical data trend for Revolution Medicines's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revolution Medicines Marketable Securities Chart

Revolution Medicines Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Marketable Securities

Get a 7-Day Free Trial

276.58

414.67

456.45

1,060.79

1,667.65

Revolution Medicines Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Marketable Securities	Get a 7-Day Free Trial															1,301.90	1,221.64	1,214.75	1,667.65	1,636.44

Revolution Medicines Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Revolution Medicines (FRA:42Z) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Revolution Medicines Marketable Securities Related Terms

Thank you for viewing the detailed overview of Revolution Medicines's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Revolution Medicines Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Revolution Medicines Inc (FRA:42Z) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

RVMD:USA 42Z:Germany

Address

700 Saginaw Drive, Redwood City, CA, USA, 94063

Website

https://www.revmed.com

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

Revolution Medicines Headlines

No Headlines